Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Enzo Biochem
(NY:
ENZ
)
3.060
USD
+0.070 (+2.34%)
Official Closing Price
Updated: 7:59 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
290,500
Open
2.980
Bid (Size)
3.060 (18)
Ask (Size)
3.200 (9)
Prev. Close
2.990
Today's Range
2.937 - 3.060
52wk Range
1.560 - 4.850
Shares Outstanding
47,165,942
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES
January 20, 2021
From
GlobeNewswire News Releases
Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc.
January 05, 2021
At a Minimum, Chairman and CEO, Dr. Elazar Rabbani, Must Tender His Resignation from the Board According to Roumell's Initial Tabulations
From
PR Newswire
Performance
YTD
+15.04%
+15.04%
1 Month
+31.33%
+31.33%
3 Month
+45.71%
+45.71%
6 Month
+27.50%
+27.50%
1 Year
+20.00%
+20.00%
More News
Read More
ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
January 05, 2021
From
GlobeNewswire News Releases
ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
January 04, 2021
From
GlobeNewswire News Releases
Leading Proxy Advisory Firms, Institutional Shareholder Services and Glass Lewis, Recommend That Shareholders Vote AGAINST Elazar Rabbani at Enzo's Upcoming Annual Meeting
December 31, 2020
From
PR Newswire
ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES
December 28, 2020
From
GlobeNewswire News Releases
Roumell Asset Management Files Definitive Proxy Statement and Sends Letter to Enzo Biochem Shareholders
December 24, 2020
From
PR Newswire
Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
December 15, 2020
From
GlobeNewswire News Releases
Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update
December 09, 2020
From
GlobeNewswire News Releases
Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9
December 02, 2020
From
GlobeNewswire News Releases
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS
November 25, 2020
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.